(Albany, US) DelveInsight launched its new report on Herpes Zoster – Market Insights, Epidemiology, and Market Forecast-2030
DelveInsight’s “Herpes Zoster – Market Insights, Epidemiology, and Market Forecast-2030″ report delivers an in-depth understanding of the Herpes Zoster, historical and forecasted epidemiology as well as the Herpes Zoster market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Some of the key facts of the report:1. Around 4% of patients develop a recurrent episode later in life. Recurrent zoster occurs almost exclusively in immunosuppressed people.2. Around 1 in 3 people in the United States will have shingles at some point in their life.
Key benefits of the report:1. Herpes Zoster market report covers a descriptive overview and comprehensive insight of the Shingles epidemiology and Shingles market in the 7 MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)2. Herpes Zoster market report provides insights on the current and emerging therapies.3. Shingles market report provides a global historical and forecasted market covering drug outreach in 7 MM.4. Herpes Zoster market report offers an edge that will help in developing business strategies by understanding trends shaping and driving the Herpes Zoster market.
Request for free sample pages: https://www.delveinsight.com/sample-request/herpes-zoster-market
“Females show a higher proportion of Herpes Zoster prevalence as compared to males in the 7MM.“
The key players in Herpes Zoster market are:1. Nobelpharma2. GC Pharma3. EyeGene
Drugs covered:1. NPC-062. CRV-1013. EG-HZ
Table of contents1. Key Insights2. Executive Summary of Herpes Zoster3. Competitive Intelligence Analysis for Herpes Zoster4. Herpes Zoster Market Overview at a Glance5. Herpes Zoster Disease Background and Overview6. Patient Journey7. Herpes Zoster Epidemiology and Patient Population8. Country Wise Herpes Zoster Epidemiology8.1. United States8.2. EU5 Countries8.3. Assumptions and Rationale8.4. Germany8.5. France8.6. Italy8.7. Spain8.8. United Kingdom8.9. Japan9. Herpes Zoster Treatment10. Herpes Zoster Treatment Algorithm11. Unmet Needs12. Herpes Zoster Marketed Drugs12.1. Shingrix: GlaxoSmithKline12.2. VARIVAX: Merck Sharp & Dohme Corp14. Herpes Zoster Emerging Drugs14.1. Key Cross Competition14.2. NPC-06:Nobelpharma14.3. CRV-101: GC Pharma14.4. EG-HZ: EyeGene15. Herpes Zoster 7 Major Market Analysis15.1. Key Findings15.2. Herpes Zoster market Size in 7MM16. Attribute analysis17. The United States Market Outlook17.1. United States Market Size18. EU-5 Countries: Market Outlook18.1. Germany18.2. France18.3. Italy18.4. Spain18.5. United Kingdom19. Japan: Market Outlook20. Access and reimbursement overview of Herpes Zoster21. KOL Views22. Market Drivers23. Market Barriers24. Appendix25. DelveInsight Capabilities26. Disclaimer27. About DelveInsight
Related reports:
Herpes Zoster Pipeline Insight, 2020
Media ContactCompany Name: DelveInsight Business Research LLPContact Person: Yash BhardwajEmail: Send EmailPhone: +919650213330Address:304 S. Jones Blvd #2432 City: AlbanyState: New YorkCountry: United StatesWebsite: https://www.delveinsight.com/